Recent Finacing
Recent Raise
Hylomorph is a Switzerland-based clinical-stage medtech company developing biosynthesized cellulose membranes and pouches (Hylomate sheet and pouch) to reduce fibrotic responses around cardiac and neurostimulation implants, seeking regulatory approval.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
